Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder after high-dose immunosuppressive therapy and autologous CD34-selected hematopoietic stem cell transplantation for severe autoimmune diseases.

Nash, Richard A

Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder after high-dose immunosuppressive therapy and autologous CD34-selected hematopoietic stem cell transplantation for severe autoimmune diseases. [electronic resource] - Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation Sep 2003 - 583-91 p. digital

Publication Type: Case Reports; Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.

1083-8791

10.1016/s1083-8791(03)00228-3 doi


Adult
Animals
Antigens, CD--analysis
Antigens, CD34--analysis
Antilymphocyte Serum--adverse effects
Autoimmune Diseases--therapy
B-Lymphocytes--chemistry
Blood Component Removal
Epstein-Barr Virus Infections--etiology
Female
Flow Cytometry
Granulocyte Colony-Stimulating Factor--pharmacology
Herpesvirus 4, Human--isolation & purification
Horses
Humans
Immunosuppressive Agents--adverse effects
Killer Cells, Natural--chemistry
Lymphoproliferative Disorders--etiology
Male
Middle Aged
Multiple Sclerosis--therapy
Neutrophils--chemistry
Opportunistic Infections--etiology
Peripheral Blood Stem Cell Transplantation--adverse effects
Platelet Transfusion
Rabbits
Scleroderma, Systemic--therapy
T-Lymphocytes--chemistry
Transplantation Conditioning--adverse effects
Transplantation, Autologous